The aims of this study were to evaluate the benefits usual dose and duration, that is, at 3 MU three times per of higher doses or of longer duration in comparison with week for 6 months, versus a control group in terms of alanine a standard interferon regimen (3 MU three times per transaminase (ALT)
β¦ LIBER β¦
Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration
β Scribed by T Poynard; V Leroy; M Cohard; T Thevenot; P Mathurin; P Opolon; JP Zarski
- Book ID
- 118686412
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 371 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Meta-analysis of interferon randomized t
β
T Poynard; V Leroy; M Cohard; T Thevenot; P Mathurin; P Opolon; J P Zarski
π
Article
π
1996
π
John Wiley and Sons
π
English
β 362 KB
π 2 views
Meta-analysis of interferon randomized t
β
Keen, P.; Nielsch, U.
π
Article
π
1995
π
John Wiley and Sons
π
English
β 162 KB
Meta-analysis of interferon randomized t
β
T. ThΓ©venot; C. Regimbeau; V. Ratziu; V. Leroy; P. Opolon; T. Poynard
π
Article
π
2008
π
John Wiley and Sons
π
English
β 488 KB
Treatment of chronic NANB and C hepatiti
β
NIEDERAU, C
π
Article
π
1995
π
John Wiley and Sons
π
English
β 150 KB
Interferon and lamivudine vs. interferon
β
Dan Rudin; Sooraj M. Shah; Alexander Kiss; Robert V. Wetz; Vincent M. Sottile
π
Article
π
2007
π
John Wiley and Sons
π
English
β 119 KB
Response-guided peg-interferon plus riba
β
Vincent Di Martino; Carine Richou; Jean-Paul Cervoni; Jose M. Sanchez-Tapias; Do
π
Article
π
2011
π
John Wiley and Sons
π
English
β 333 KB
π 1 views
Response-guided pegylated interferon (peg-IFN) plus ribavirin (P/R) therapy trials on genotype (G)1 and G2/G3 hepatitis C virus-infected patients provide contradictory results. We conducted meta-analyses of randomized, controlled trials to address (1) the benefit of a 72-week extended-duration thera